Immunovant (NASDAQ: IMVT) COO sells shares in sell-to-cover tax move
Rhea-AI Filing Summary
Immunovant, Inc. (IMVT) reported that Chief Operating Officer Gloria Melanie sold 3,056 shares of common stock on August 20, 2026, at a weighted average price of $44.16 per share. The shares were sold to cover tax withholding obligations arising from the vesting and settlement of previously granted RSUs under a mandated “sell to cover” arrangement, and are described as not being a discretionary transaction by the officer. Following this sale, she holds 219,301 shares of Immunovant common stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 3,056 shares
Net Sell
1 txn
Insider
Gloria Melanie
Role
Chief Operating Officer
Sold
3,056 shs ($135K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 3,056 | $44.16 | $135K |
Holdings After Transaction:
Common Stock — 219,301 shares (Direct)
Footnotes (2)
- F1. On November 18, 2024, the holder was granted 109,956 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on November 20, 2024, of which 6,872 of these RSUs vested on August 18, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.80 - $44.37 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Key Figures
Shares sold: 3,056 shares
Weighted average sale price: $44.16 per share
Post-transaction holdings: 219,301 shares
+3 more
6 metrics
Shares sold
3,056 shares
Common stock sold by COO Gloria Melanie on August 20, 2026
Weighted average sale price
$44.16 per share
Weighted average price for the 3,056 shares sold
Post-transaction holdings
219,301 shares
Common stock directly held by Gloria Melanie after the sale
RSUs granted
109,956 RSUs
Restricted stock units granted on November 18, 2024
RSUs vested
6,872 RSUs
Portion of RSUs that vested on August 18, 2026
Sale price range
$43.80–$44.37 per share
Range of prices for multiple transactions making up the sale
Key Terms
restricted stock units ("RSUs"), sell to cover, weighted average price
3 terms
restricted stock units ("RSUs") financial
"the holder was granted 109,956 restricted stock units ("RSUs"), as previously"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
sell to cover financial
"require the satisfaction of tax withholding obligations to be funded by a "sell to cover""
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
weighted average price financial
"The price reported is a weighted average price. These shares were sold"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
FAQ
What insider transaction did Immunovant (IMVT) disclose for Gloria Melanie?
Immunovant disclosed that COO Gloria Melanie sold 3,056 shares of common stock on August 20, 2026 at a weighted average price of $44.16 per share, in connection with tax withholding on vested RSUs.
What equity awards underpin the reported Immunovant (IMVT) tax-withholding sale?
On November 18, 2024, the reporting person was granted 109,956 restricted stock units (RSUs). Of these, 6,872 RSUs vested on August 18, 2026, and the associated tax withholding obligations led to the sell-to-cover transaction reported.
Was the Immunovant (IMVT) Form 4 sale under a Rule 10b5-1 plan?
The Rule 10b5-1 checkbox is not marked as a plan transaction. Instead, the footnote explains the sale was mandated by the issuer’s election to use a “sell to cover” method for tax withholding on RSU vesting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
